In mouse intestinal epithelial cells, IL-21 increases the risk of IBD-CRC by enhancing the expression of induced cytidine deaminase gene which deaminates cytosine residues to cause cytosine-to-thymine transitions. The gene discussed is IL21; the disease is inflammatory bowel disease.